J Kumar Infraprojects Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 29, 2025, 5:25 am

Competitors of J Kumar Infraprojects Ltd

All Competitor Stocks of J Kumar Infraprojects Ltd

Quarterly Result

Last Updated: August 1, 2025, 7:05 pm

Below is a detailed analysis of the quarterly data for J Kumar Infraprojects Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,479.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,633.00 Cr. (Mar 2025) to 1,479.00 Cr., marking a decrease of 154.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,263.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,398.00 Cr. (Mar 2025) to 1,263.00 Cr., marking a decrease of 135.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 216.00 Cr.. The value appears to be declining and may need further review. It has decreased from 235.00 Cr. (Mar 2025) to 216.00 Cr., marking a decrease of 19.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Mar 2025) to 15.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 38.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 43.00 Cr. (Mar 2025) to 38.00 Cr., marking a decrease of 5.00 Cr..
• For Depreciation, as of Jun 2025, the value is 45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 45.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 157.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 13.00 Cr..
• For Tax %, as of Jun 2025, the value is 29.00%. The value appears to be increasing, which may not be favorable. It has increased from 27.00% (Mar 2025) to 29.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 103.00 Cr.. The value appears to be declining and may need further review. It has decreased from 114.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 11.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 13.58. The value appears to be declining and may need further review. It has decreased from 15.08 (Mar 2025) to 13.58, marking a decrease of 1.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 18, 2025, 4:17 am

Growth

Last Updated: September 5, 2025, 8:00 am

Balance Sheet

Last Updated: September 10, 2025, 1:52 pm

Below is a detailed analysis of the balance sheet data for J Kumar Infraprojects Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 38.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,967.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,604.00 Cr. (Mar 2024) to 2,967.00 Cr., marking an increase of 363.00 Cr..
• For Borrowings, as of Mar 2025, the value is 673.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 593.00 Cr. (Mar 2024) to 673.00 Cr., marking an increase of 80.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,935.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,473.00 Cr. (Mar 2024) to 1,935.00 Cr., marking an increase of 462.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 5,612.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,708.00 Cr. (Mar 2024) to 5,612.00 Cr., marking an increase of 904.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 971.00 Cr. (Mar 2024) to 1,149.00 Cr., marking an increase of 178.00 Cr..
• For CWIP, as of Mar 2025, the value is 98.00 Cr.. The value appears to be declining and may need further review. It has decreased from 111.00 Cr. (Mar 2024) to 98.00 Cr., marking a decrease of 13.00 Cr..
• For Investments, as of Mar 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 4,363.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,625.00 Cr. (Mar 2024) to 4,363.00 Cr., marking an increase of 738.00 Cr..
• For Total Assets, as of Mar 2025, the value is 5,612.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,708.00 Cr. (Mar 2024) to 5,612.00 Cr., marking an increase of 904.00 Cr..

Notably, the Reserves (2,967.00 Cr.) exceed the Borrowings (673.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for J Kumar Infraprojects Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 43.71 (Mar 24) to 51.70, marking an increase of 7.99.
• For Diluted EPS (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 43.71 (Mar 24) to 51.70, marking an increase of 7.99.
• For Cash EPS (Rs.), as of Mar 25, the value is 73.91. This value is within the healthy range. It has increased from 65.63 (Mar 24) to 73.91, marking an increase of 8.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 397.50. It has increased from 349.44 (Mar 24) to 397.50, marking an increase of 48.06.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 397.50. It has increased from 349.44 (Mar 24) to 397.50, marking an increase of 48.06.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 752.45. It has increased from 644.84 (Mar 24) to 752.45, marking an increase of 107.61.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 113.58. This value is within the healthy range. It has increased from 96.80 (Mar 24) to 113.58, marking an increase of 16.78.
• For PBIT / Share (Rs.), as of Mar 25, the value is 91.27. This value is within the healthy range. It has increased from 74.60 (Mar 24) to 91.27, marking an increase of 16.67.
• For PBT / Share (Rs.), as of Mar 25, the value is 70.77. This value is within the healthy range. It has increased from 58.23 (Mar 24) to 70.77, marking an increase of 12.54.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 51.60. This value is within the healthy range. It has increased from 43.43 (Mar 24) to 51.60, marking an increase of 8.17.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 51.70. This value is within the healthy range. It has increased from 43.71 (Mar 24) to 51.70, marking an increase of 7.99.
• For PBDIT Margin (%), as of Mar 25, the value is 15.09. This value is within the healthy range. It has increased from 15.01 (Mar 24) to 15.09, marking an increase of 0.08.
• For PBIT Margin (%), as of Mar 25, the value is 12.12. This value is within the healthy range. It has increased from 11.56 (Mar 24) to 12.12, marking an increase of 0.56.
• For PBT Margin (%), as of Mar 25, the value is 9.40. This value is below the healthy minimum of 10. It has increased from 9.02 (Mar 24) to 9.40, marking an increase of 0.38.
• For Net Profit Margin (%), as of Mar 25, the value is 6.85. This value is within the healthy range. It has increased from 6.73 (Mar 24) to 6.85, marking an increase of 0.12.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.87. This value is below the healthy minimum of 8. It has increased from 6.77 (Mar 24) to 6.87, marking an increase of 0.10.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 15. It has increased from 12.50 (Mar 24) to 13.00, marking an increase of 0.50.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.31. This value is within the healthy range. It has increased from 19.17 (Mar 24) to 20.31, marking an increase of 1.14.
• For Return On Assets (%), as of Mar 25, the value is 6.90. This value is within the healthy range. It has decreased from 7.02 (Mar 24) to 6.90, marking a decrease of 0.12.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.23. This value is within the healthy range. It has increased from 0.21 (Mar 24) to 0.23, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.10. It has increased from 1.08 (Mar 24) to 1.10, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.75. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.75, marking a decrease of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 1.53. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 1.53, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.54. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 11.54, marking an increase of 11.54.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.73. This value is below the healthy minimum of 20. It has decreased from 8.00 (Mar 24) to 7.73, marking a decrease of 0.27.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.40. This value is below the healthy minimum of 20. It has increased from 5.30 (Mar 24) to 5.40, marking an increase of 0.10.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.27. This value exceeds the healthy maximum of 70. It has increased from 92.00 (Mar 24) to 92.27, marking an increase of 0.27.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.60. This value exceeds the healthy maximum of 70. It has decreased from 94.70 (Mar 24) to 94.60, marking a decrease of 0.10.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 5.91 (Mar 24) to 5.54, marking a decrease of 0.37.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.52. This value is within the healthy range. It has decreased from 3.65 (Mar 24) to 3.52, marking a decrease of 0.13.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,665.46. It has decreased from 4,848.51 (Mar 24) to 4,665.46, marking a decrease of 183.05.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 24) to 0.81, marking a decrease of 0.18.
• For EV / EBITDA (X), as of Mar 25, the value is 5.43. This value is within the healthy range. It has decreased from 6.62 (Mar 24) to 5.43, marking a decrease of 1.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.84, marking a decrease of 0.13.
• For Retention Ratios (%), as of Mar 25, the value is 92.26. This value exceeds the healthy maximum of 70. It has increased from 91.99 (Mar 24) to 92.26, marking an increase of 0.27.
• For Price / BV (X), as of Mar 25, the value is 1.60. This value is within the healthy range. It has decreased from 1.81 (Mar 24) to 1.60, marking a decrease of 0.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.84, marking a decrease of 0.13.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.06 (Mar 24) to 0.08, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness